M&A Deal Summary

GlaxoSmithKline Acquires Reliant Pharmaceuticals

On December 19, 2007, GlaxoSmithKline acquired life science company Reliant Pharmaceuticals from Bay City Capital for 1.7B USD

Acquisition Highlights
  • This is GlaxoSmithKline’s 8th transaction in the Life Science sector.
  • This is GlaxoSmithKline’s 9th largest (disclosed) transaction.
  • This is GlaxoSmithKline’s 7th transaction in the United States.
  • This is GlaxoSmithKline’s 2nd transaction in New Jersey.

M&A Deal Summary

Date 2007-12-19
Target Reliant Pharmaceuticals
Sector Life Science
Buyer(s) GlaxoSmithKline
Sellers(s) Bay City Capital
Deal Type Add-on Acquisition
Deal Value 1.7B USD

Target

Reliant Pharmaceuticals

Liberty Corner, New Jersey, United States
Reliant Pharmaceuticals, Inc. is a pharmaceutical company.

Search 192,611 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

GlaxoSmithKline

Brentford, United Kingdom

website


Category Company
Founded 1715
Sector Life Science
Employees94,066
Revenue 34.1B GBP (2020)
DESCRIPTION
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.
Entrance to a GlaxoSmithKline facility in Morristown, New Jersey.

GlaxoSmithKline is a multinational pharmaceutical, biologics, vaccines and consumer healthcare company. GlaxoSmithKline was founded in 1715 and is based in Brentford, the United Kingdom.


DEAL STATS #
Overall 9 of 31
Sector (Life Science) 8 of 25
Type (Add-on Acquisition) 7 of 23
State (New Jersey) 2 of 2
Country (United States) 7 of 18
Year (2007) 2 of 2
Size (of disclosed) 9 of 27
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-02-16 Praecis Pharmaceuticals

Waltham, Maine, United States

Praecis Pharmaceuticals, Inc. is a biopharmaceutical company focused on utilizing its proprietary technologies for the discovery and development of novel compounds that have the potential to address unmet medical needs or improve existing therapies. PRAECIS has a novel MetAP-2 inhibitor, PPI-2458, in clinical development for cancer indications, including non-Hodgkin’s lymphoma and solid tumors, an innovative drug discovery technology, DirectSelect™, which enables the generation and practical use of ultra-large libraries for the discovery of orally active compounds for drug development, and a research and development program aimed at identifying one or more selective S1P-1 agonist compounds to advance into clinical testing.

Buy $55M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-04-22 Sirtris Pharmaceuticals

Cambridge, Massachusetts, United States

Sirtris Pharmaceuticals is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes. Our drug candidates are designed to mimic certain beneficial health effects of calorie restriction by activation of sirtuins, a recently discovered class of enzymes that the Company believes control the ageing process.

Buy $720M

Seller(S) 1

SELLER

Bay City Capital

San Rafael, California, United States

Investor Investor Investor Investor Investor

website


Category Venture Capital Firm
Founded 1997
PE ASSETS 1.3B USD
Size Large
Type Sector Focused
DESCRIPTION

Bay City Capital LLC was established in 1997 as an equal partnership between The Craves Group and certain Pritzker family business interests for the purpose of managing investment funds in the life sciences industry. Bay City looks for opportunities at all stages of development in biopharmaceuticals, drug discovery, medical devices and diagnostics. Bay City Capital is based in San Francisco, California.


DEAL STATS #
Overall 25 of 62
Sector (Life Science) 16 of 45
Type (Add-on Acquisition) 12 of 31
State (New Jersey) 2 of 3
Country (United States) 23 of 59
Year (2007) 4 of 4
Size (of disclosed) 1 of 18
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-12-01 Aragon Surgical

Palo Alto, California, United States

Aragon Surgical, Inc. is a manufacturers of surgical instruments and sterilization container systems.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-02-20 Cadence Pharmaceuticals

San Diego, California, United States

Cadence Pharmaceuticals, Inc. is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.

Buy -